HNO258 Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Head-Neck cancer cell lines |
| Organism |
Human |
| Donor History |
Head and neck squamous cell carcinoma (HNSCC) |
| Growth Properties |
Monolayer ,adherent |
| Growth Conditions |
Culture medium: DMEM ,w: 4.5 g/L Glucose ,w: 4 mM L-Glutamine ,w: 3.7 g/L NaHCO3 ,w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The HNO258 cell line is derived from an oral squamous cell carcinoma, which is a subtype of head and neck squamous cell carcinoma (HNSCC). This cell line exhibits several chromosomal abnormalities, which have been identified through chromosomal comparative genomic hybridization (cCGH). Specifically, HNO258 has shown DNA copy number gains in the chromosomal regions 1q41, 3q21-qter, 7p, 7cen-q21, 8q22-qter, 9cen-p13, 9q31-qter, 11q13, 15p, and 15q. Additionally, it displays copy number losses in the regions 4p and 18q12-qter. These genetic alterations are common in HNSCC and are associated with tumorigenesis and cancer progression.
The amplification of 11q13, observed in HNO258, is particularly noteworthy due to its association with the overexpression of oncogenes such as CCND1 (cyclin D1) and CTTN (cortactin), which are involved in cell cycle regulation and cytoskeletal organization, respectively. These oncogenes are frequently implicated in the aggressive behavior of cancer cells, contributing to increased proliferation and invasiveness. The detailed genetic characterization of HNO258 makes it a valuable model for studying the molecular mechanisms underlying oral squamous cell carcinoma and for evaluating potential therapeutic strategies that target these specific genetic alterations.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

